What is the most common organism causing acute infectious colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Organisms Causing Colitis

Clostridioides difficile (C. difficile) is the most common identifiable infectious cause of colitis in hospitalized patients, accounting for 10-25% of all antibiotic-associated diarrhea cases and representing the dominant nosocomial pathogen. 1, 2, 3

Context-Dependent Etiology

The causative organism varies significantly based on clinical setting and patient characteristics:

Healthcare-Associated Colitis (Nosocomial)

  • C. difficile is overwhelmingly the primary pathogen in hospital-acquired colitis, particularly after ≥3 days of hospitalization 4, 1
  • After 3 days of hospitalization, standard enteric bacterial pathogens (Salmonella, Shigella, Campylobacter) become exceedingly rare, and routine stool cultures yield extremely low diagnostic value 1
  • C. difficile is the main pathogen associated with nosocomial infections and the most common cause of diarrhea in hospitalized patients 4

Community-Acquired Infectious Colitis

When patients present with diarrhea at admission or develop colitis in the community, the most frequent invasive bacterial enteropathogens include 4, 5:

  • Campylobacter jejuni
  • Salmonella species (nontyphoid)
  • Shigella species
  • Shiga toxin-producing E. coli (STEC), particularly E. coli O157:H7

These four organisms represent the standard bacterial pathogens tested in stool cultures for community-acquired infectious colitis 4, 5

High-Risk Populations Requiring Broader Testing

Certain patient populations warrant expanded microbiologic evaluation beyond C. difficile 1:

  • Immunocompromised patients (HIV-positive, transplant recipients, those on immunosuppressive therapy) may develop cytomegalovirus (CMV) colitis, which has high mortality if misdiagnosed 4
  • Patients >65 years with significant comorbidities or neutropenia 1
  • Recent international travelers or those from parasite-endemic regions may harbor Entamoeba histolytica or other parasitic causes 5, 6

Special Considerations for Immunocompromised Patients

  • In transplanted patients, intestinal perforation due to diverticulitis is common following kidney and liver transplants 4
  • CMV colitis should be suspected in patients with moderate to severe colitis, particularly those with corticosteroid-refractory disease 4
  • Neutropenic enteritis (typhlitis) requires nonoperative management with broad-spectrum antibiotics unless perforation or ischemia develops 4

Critical Diagnostic Algorithm

For hospitalized patients developing diarrhea:

  1. First-line testing: Single stool specimen for C. difficile toxin assay, especially if antibiotics received within 30 days 4, 1

  2. If C. difficile negative AND no recent antibiotic use: Submit stool for culture targeting Campylobacter, Salmonella, Shigella, and E. coli O157:H7 4

  3. Do NOT routinely culture after ≥3 days hospitalization unless patient was admitted with diarrhea, is HIV-positive, or part of outbreak investigation 1

  4. Multiplex antimicrobial testing is now preferred over traditional stool cultures and microscopy 7

Common Pitfalls to Avoid

  • Never use antimotility agents (loperamide, diphenoxylate) when C. difficile or any infectious colitis is suspected, as they can precipitate toxic megacolon 1, 2
  • Recognize that absence of diarrhea does not exclude C. difficile—fulminant infection may present with ileus or toxic megacolon without diarrhea, particularly postoperatively 2, 3
  • Alcohol-based hand sanitizers do not kill C. difficile spores; handwashing with soap and water is essential for infection control 4
  • Environmental contamination with C. difficile spores can persist for months on surfaces, facilitating nosocomial transmission 4, 8

Risk Factors for C. difficile Colitis

The following increase risk 7-10 times 2:

  • Antibiotic exposure (especially clindamycin, third-generation cephalosporins, fluoroquinolones, carbapenems)
  • Advanced age >65 years
  • Proton pump inhibitor use
  • Hospitalization or long-term care facility residence
  • Chemotherapy for cancer

References

Guideline

Guideline for Stool Testing in Hospitalized Adults with Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Clostridium Difficile Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diarrhea in Dialysis Patients: Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Approach to the patient with infectious colitis.

Current opinion in gastroenterology, 2012

Research

Infectious colitis.

Current opinion in gastroenterology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.